Literature DB >> 2271782

Monosomy 7 provides a proliferative advantage for leukemic cells under incubation with GM-CSF in vitro.

D Haase, C Fonatsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2271782     DOI： 10.1007/bf01732888

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


× No keyword cloud information.
  8 in total

1.  Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Report of the Workshop held in Leuven, Belgium, September 15-17, 1986. Second MIC Cooperative Study Group.

Authors: 
Journal:  Cancer Genet Cytogenet       Date:  1988-01

2.  Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome.

Authors:  J H Antin; B R Smith; W Holmes; D S Rosenthal
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

3.  Karyotype and in vitro-response to GM-CSF. Analysis of bone marrow cultures in leukemia, myelodysplasia and aplastic anemia.

Authors:  D Haase; C Fonatsch
Journal:  Blut       Date:  1990-03

4.  Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia.

Authors:  J J Yunis; M Lobell; M A Arnesen; M M Oken; M G Mayer; R E Rydell; R D Brunning
Journal:  Br J Haematol       Date:  1988-02       Impact factor: 6.998

5.  Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.

Authors:  S Vadhan-Raj; M Keating; A LeMaistre; W N Hittelman; K McCredie; J M Trujillo; H E Broxmeyer; C Henney; J U Gutterman
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

6.  Constitutive expression of the granulocyte-macrophage colony-stimulating factor gene in acute myeloblastic leukemia.

Authors:  D C Young; K Wagner; J D Griffin
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

7.  Effects of recombinant human GM-CSF on proliferation of clonogenic cells in acute myeloblastic leukemia.

Authors:  J D Griffin; D Young; F Herrmann; D Wiper; K Wagner; K D Sabbath
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

8.  Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes--a phase I/II trial.

Authors:  A Ganser; B Völkers; J Greher; O G Ottmann; F Walther; R Becher; L Bergmann; G Schulz; D Hoelzer
Journal:  Blood       Date:  1989-01       Impact factor: 22.113
  8 in total
  4 in total

1.  A case of congenital leukemia with monosomy 7.

Authors:  T Shitara; N Suetake; S Yugami; M Sotomatu; Y Oshima; H Ijima; T Kuroume; S Nakazawa
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

2.  Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.

Authors:  Susan M Grant; Rennie C Heel
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

3.  Cytogenetic findings in 179 patients with myelodysplastic syndromes.

Authors:  D Haase; C Fonatsch; M Freund; B Wörmann; H Bodenstein; H Bartels; B Stollmann-Gibbels; E Lengfelder
Journal:  Ann Hematol       Date:  1995-04       Impact factor: 3.673

Review 4.  Cytogenetic features in myelodysplastic syndromes.

Authors:  Detlef Haase
Journal:  Ann Hematol       Date:  2008-04-15       Impact factor: 3.673
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.